Medicamen Biotech Limited (MEDICAMEQ.NS) NSE

408.50

-3.2(-0.78%)

Updated at November 14 01:24PM

Currency In INR

Valuation

Market Cap6.27B
Enterprise Value6.57B
P/E Ratio61.92
PEG Ratio33.08
Price/Sales Ratio3.41
Price/Book Ratio2.6
Enterprise/Revenue3.41
Enterprise/EBITDA26.19

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.05

Management Effectiveness

Return On Assets0
Return On Equity0.04

Income Statement

Revenue1.63B
Revenue/Share119.84
Gross Profit389.9M
EBITDA201.02M
Net Income71.08M
Diluted EPS5.59

Balance Sheet

Total Cash37.59M
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share156.89

Price History

52-Week Change-11.01
52-Week High630
52-Week Low292.95
Moving Average 50 Days341.73
Moving Average 200 Days410.39

Statistics

Average Volume31,539
Shares Outstanding13.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield0.24
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A